Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Neoplasms of the CNS

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 419 articles:
HTML format



Single Articles


    January 2021
  1. WHITE ML, Zhang Y, Kazmi SAJ, Aizenberg M, et al
    Evaluating survival in subjects with astrocytic brain tumors by dynamic susceptibility-weighted perfusion MR imaging.
    PLoS One. 2021;16:e0244275.
    PubMed     Abstract available


  2. SHI H, Song Y, Song Z, Huang C, et al
    CKMT1B is a potential prognostic biomarker and associated with immune infiltration in Lower-grade glioma.
    PLoS One. 2021;16:e0245524.
    PubMed     Abstract available


  3. ZHAO Y, Zhang X, Yao J
    Comprehensive analysis of PLOD family members in low-grade gliomas using bioinformatics methods.
    PLoS One. 2021;16:e0246097.
    PubMed     Abstract available


  4. LIM J, Park Y, Ahn JW, Hwang SJ, et al
    Maximal surgical resection and adjuvant surgical technique to prolong the survival of adult patients with thalamic glioblastoma.
    PLoS One. 2021;16:e0244325.
    PubMed     Abstract available


  5. YU VY, Nguyen D, O'Connor D, Ruan D, et al
    Treating Glioblastoma Multiforme (GBM) with super hyperfractionated radiation therapy: Implication of temporal dose fractionation optimization including cancer stem cell dynamics.
    PLoS One. 2021;16:e0245676.
    PubMed     Abstract available


  6. ALI S, Borin TF, Piranlioglu R, Ara R, et al
    Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study.
    PLoS One. 2021;16:e0246646.
    PubMed     Abstract available


  7. JUNG HW, Kim HY, Kim JY, Cheon JE, et al
    Cardiac autonomic dysfunction is associated with hypothalamic damage in patients with childhood-onset craniopharyngioma.
    PLoS One. 2021;16:e0246789.
    PubMed     Abstract available


  8. CAVATORTA C, Meroni S, Montin E, Oprandi MC, et al
    Retrospective study of late radiation-induced damages after focal radiotherapy for childhood brain tumors.
    PLoS One. 2021;16:e0247748.
    PubMed     Abstract available


  9. JIANG Z, Shi Y, Tan G, Wang Z, et al
    Computational screening of potential glioma-related genes and drugs based on analysis of GEO dataset and text mining.
    PLoS One. 2021;16:e0247612.
    PubMed     Abstract available


  10. BOLCAEN J, Descamps B, Deblaere K, De Vos F, et al
    Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI.
    PLoS One. 2021;16:e0248193.
    PubMed     Abstract available


  11. LAMMER F, Delbridge C, Wurstle S, Neff F, et al
    Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.
    PLoS One. 2021;16:e0248612.
    PubMed     Abstract available


  12. LIM J, Park Y, Ahn JW, Sim J, et al
    Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial.
    PLoS One. 2021;16:e0247293.
    PubMed     Abstract available


  13. YE ZP, He HY, Wang H, Li WS, et al
    Retraction: Glioma-Derived ADAM10 Induces Regulatory B Cells to Suppress CD8+ T Cells.
    PLoS One. 2021;16:e0249104.
    PubMed    


  14. CAO Y, Yang R, Lee I, Zhang W, et al
    Prediction of LncRNA-encoded small peptides in glioma and oligomer channel functional analysis using in silico approaches.
    PLoS One. 2021;16:e0248634.
    PubMed     Abstract available



  15. Correction: Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
    PLoS One. 2021;16:e0250189.
    PubMed     Abstract available


  16. PROST DM, Merenzon MA, Gomez-Escalante JI, Primavera A, et al
    Effects of time to chemoradiation on high-grade gliomas from the Buenos Aires Metropolitan Area.
    PLoS One. 2021;16:e0249486.
    PubMed     Abstract available


  17. GIHR G, Horvath-Rizea D, Hekeler E, Ganslandt O, et al
    Diffusion weighted imaging in high-grade gliomas: A histogram-based analysis of apparent diffusion coefficient profile.
    PLoS One. 2021;16:e0249878.
    PubMed     Abstract available


  18. NONAKA M, Mabashi-Asazuma H, Jarvis DL, Yamasaki K, et al
    Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides.
    PLoS One. 2021;16:e0241157.
    PubMed     Abstract available


  19. WANG L, Liu Y, Xuan C, Liu Y, et al
    Identification of ubiquitination-related genes in human glioma as indicators of patient prognosis.
    PLoS One. 2021;16:e0250239.
    PubMed     Abstract available


  20. WILLIFORD SE, Libby CJ, Ayokanmbi A, Otamias A, et al
    Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells.
    PLoS One. 2021;16:e0250649.
    PubMed     Abstract available



  21. Correction: Three-dimensional visualization of brain tumor progression based accurate segmentation via comparative holographic projection.
    PLoS One. 2021;16:e0251614.
    PubMed     Abstract available


  22. SHIN C, Kim JM, Cheong JH, Ryu JI, et al
    Association between tumor size and peritumoral brain edema in patients with convexity and parasagittal meningiomas.
    PLoS One. 2021;16:e0252945.
    PubMed     Abstract available


  23. DORRELL MI, Kast-Woelbern HR, Botts RT, Bravo SA, et al
    A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis.
    PLoS One. 2021;16:e0252233.
    PubMed     Abstract available


  24. GARRETT C, Becker TM, Lynch D, Po J, et al
    Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
    PLoS One. 2021;16:e0252614.
    PubMed     Abstract available


  25. ROY S, Maji P
    Multispectral co-occurrence of wavelet coefficients for malignancy assessment of brain tumors.
    PLoS One. 2021;16:e0250964.
    PubMed     Abstract available


  26. LIU H, Chen C, Zeng J, Zhao Z, et al
    MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells.
    PLoS One. 2021;16:e0253522.
    PubMed     Abstract available


  27. FUCHS J, Fruh M, Papachristofilou A, Bubendorf L, et al
    Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients - evaluation of outcome and prognostic factors: A retrospective multicenter study.
    PLoS One. 2021;16:e0253601.
    PubMed     Abstract available


  28. LEE S, Choi SH, Cho HR, Koh J, et al
    Multiparametric magnetic resonance imaging features of a canine glioblastoma model.
    PLoS One. 2021;16:e0254448.
    PubMed     Abstract available


  29. JOHANN P, Lenz D, Ries M
    The drug development pipeline for glioblastoma-A cross sectional assessment of the FDA Orphan Drug Product designation database.
    PLoS One. 2021;16:e0252924.
    PubMed     Abstract available


  30. HEYDASCH U, Kessler R, Warnke JP, Eschrich K, et al
    Functional diversity of PFKFB3 splice variants in glioblastomas.
    PLoS One. 2021;16:e0241092.
    PubMed     Abstract available


  31. CHANG LS, Oblinger JL, Smith AE, Ferrer M, et al
    Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.
    PLoS One. 2021;16:e0252048.
    PubMed     Abstract available


  32. ALENDA C, Rojas E, Valor LM
    FFPE samples from cavitational ultrasonic surgical aspirates are suitable for RNA profiling of gliomas.
    PLoS One. 2021;16:e0255168.
    PubMed     Abstract available


    January 2020
  33. WITULLA B, Goerig N, Putz F, Frey B, et al
    On PTV definition for glioblastoma based on fiber tracking of diffusion tensor imaging data.
    PLoS One. 2020;15:e0227146.
    PubMed     Abstract available



  34. Retraction: MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7.
    PLoS One. 2020;15:e0228340.
    PubMed    


  35. ROTKOPF LT, Wiestler B, Preibisch C, Liesche-Starnecker F, et al
    The wavelet power spectrum of perfusion weighted MRI correlates with tumor vascularity in biopsy-proven glioblastoma samples.
    PLoS One. 2020;15:e0228030.
    PubMed     Abstract available


  36. OTTENSMEIER H, Schlegel PG, Eyrich M, Wolff JE, et al
    Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment.
    PLoS One. 2020;15:e0227693.
    PubMed     Abstract available


  37. LI J, Liu S, Qin Y, Zhang Y, et al
    High-order radiomics features based on T2 FLAIR MRI predict multiple glioma immunohistochemical features: A more precise and personalized gliomas management.
    PLoS One. 2020;15:e0227703.
    PubMed     Abstract available



  38. Retraction: MMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells.
    PLoS One. 2020;15:e0228689.
    PubMed    



  39. Retraction: Co-Depletion of Cathepsin B and uPAR Induces G0/G1 Arrest in Glioma via FOXO3a Mediated p27Kip1 Upregulation.
    PLoS One. 2020;15:e0228690.
    PubMed    



  40. Retraction: uPAR/Cathepsin B Overexpression Reverse Angiogenesis by Rescuing FAK Phosphorylation in uPAR/Cathepsin B Down Regulated Meningioma.
    PLoS One. 2020;15:e0228681.
    PubMed    


  41. MOBARK NA, Alharbi M, Alhabeeb L, AlMubarak L, et al
    Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia.
    PLoS One. 2020;15:e0228356.
    PubMed     Abstract available



  42. Retraction: Downregulation of uPAR and Cathepsin B Induces Apoptosis via Regulation of Bcl-2 and Bax and Inhibition of the PI3K/Akt Pathway in Gliomas.
    PLoS One. 2020;15:e0228688.
    PubMed    


  43. RYU JY, Min KL, Chang MJ
    Correction: Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: A retrospective, single-center study.
    PLoS One. 2020;15:e0228800.
    PubMed     Abstract available


  44. WERLENIUS K, Fekete B, Blomstrand M, Caren H, et al
    Patterns of care and clinical outcome in assumed glioblastoma without tissue diagnosis: A population-based study of 131 consecutive patients.
    PLoS One. 2020;15:e0228480.
    PubMed     Abstract available



  45. Retraction: Differential SELEX in Human Glioma Cell Lines.
    PLoS One. 2020;15:e0228838.
    PubMed    


  46. LEE RH, Kim JM, Cheong JH, Ryu JI, et al
    Significance of skull osteoporosis to the development of peritumoral brain edema after LINAC-based radiation treatment in patients with intracranial meningioma.
    PLoS One. 2020;15:e0226312.
    PubMed     Abstract available



  47. Correction to Retraction of: EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell Growth.
    PLoS One. 2020;15:e0230016.
    PubMed     Abstract available


  48. BELTER A, Barciszewski J, Barciszewska AM
    Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions.
    PLoS One. 2020;15:e0229534.
    PubMed     Abstract available


  49. BEHLING F, Barrantes-Freer A, Behnes CL, Stockhammer F, et al
    Expression of Olig2, Nestin, NogoA and AQP4 have no impact on overall survival in IDH-wildtype glioblastoma.
    PLoS One. 2020;15:e0229274.
    PubMed     Abstract available


  50. MCKELVEY KJ, Hudson AL, Prasanna Kumar R, Wilmott JS, et al
    Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model.
    PLoS One. 2020;15:e0226444.
    PubMed     Abstract available



  51. Expression of Concern: ZEB2 Mediates Multiple Pathways Regulating Cell Proliferation, Migration, Invasion, and Apoptosis in Glioma.
    PLoS One. 2020;15:e0231386.
    PubMed    



  52. Retraction: Upregulation of PTEN in Glioma Cells by Cord Blood Mesenchymal Stem Cells Inhibits Migration via Downregulation of the PI3K/Akt Pathway.
    PLoS One. 2020;15:e0231283.
    PubMed    


  53. MASSEY SC, White H, Whitmire P, Doyle T, et al
    Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma.
    PLoS One. 2020;15:e0230492.
    PubMed     Abstract available


  54. CHAGAS SARAIVA CW, Cardoso SC, Groppo DP, De Salles AAF, et al
    Gamma Knife radiosurgery for vestibular schwannomas: Evaluation of planning using the sphericity degree of the target volume.
    PLoS One. 2020;15:e0225638.
    PubMed     Abstract available


  55. FUENFGELD B, Machler P, Fischer DR, Esposito G, et al
    Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination.
    PLoS One. 2020;15:e0230618.
    PubMed     Abstract available


  56. HYUN DG, Choi CM, Lee DH, Kim SW, et al
    Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis.
    PLoS One. 2020;15:e0231546.
    PubMed     Abstract available


  57. GIRARD A, Saint-Jalmes H, Chaboub N, Le Reste PJ, et al
    Optimization of time frame binning for FDOPA uptake quantification in glioma.
    PLoS One. 2020;15:e0232141.
    PubMed     Abstract available


  58. FABRE MS, Stanton NM, Slatter TL, Lee S, et al
    The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapy.
    PLoS One. 2020;15:e0231470.
    PubMed     Abstract available


  59. SHIEH LT, Guo HR, Ho CH, Lin LC, et al
    Survival of glioblastoma treated with a moderately escalated radiation dose-Results of a retrospective analysis.
    PLoS One. 2020;15:e0233188.
    PubMed     Abstract available


  60. SUAREZ-GARCIA JG, Hernandez-Lopez JM, Moreno-Barbosa E, de Celis-Alonso B, et al
    A simple model for glioma grading based on texture analysis applied to conventional brain MRI.
    PLoS One. 2020;15:e0228972.
    PubMed     Abstract available


  61. MIRCHI N, Bissonnette V, Yilmaz R, Ledwos N, et al
    The Virtual Operative Assistant: An explainable artificial intelligence tool for simulation-based training in surgery and medicine.
    PLoS One. 2020;15:e0229596.
    PubMed     Abstract available


  62. VAIDYA M, Sugaya K
    Differential sequences and single nucleotide polymorphism of exosomal SOX2 DNA in cancer.
    PLoS One. 2020;15:e0229309.
    PubMed     Abstract available


  63. HUA B, Ding X, Xiong M, Zhang F, et al
    Alterations of functional and structural connectivity in patients with brain metastases.
    PLoS One. 2020;15:e0233833.
    PubMed     Abstract available


  64. LEE JH, Kim HS, Yoon YC, Cha MJ, et al
    Differentiating between spinal schwannomas and meningiomas using MRI: A focus on cystic change.
    PLoS One. 2020;15:e0233623.
    PubMed     Abstract available


  65. AHLSTEDT J, Konradsson E, Ceberg C, Redebrandt HN, et al
    Increased effect of two-fraction radiotherapy in conjunction with IDO1 inhibition in experimental glioblastoma.
    PLoS One. 2020;15:e0233617.
    PubMed     Abstract available


  66. ZHU L, Nazeri A, Pacia CP, Yue Y, et al
    Focused ultrasound for safe and effective release of brain tumor biomarkers into the peripheral circulation.
    PLoS One. 2020;15:e0234182.
    PubMed     Abstract available



  67. Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFkappaB Transactivation through NIK/IKK in Human Glioma Cells.
    PLoS One. 2020;15:e0234365.
    PubMed    


  68. TAKASHIMA Y, Kawaguchi A, Iwadate Y, Hondoh H, et al
    miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.
    PLoS One. 2020;15:e0229577.
    PubMed     Abstract available


  69. BHOWMICK R, Sarkar RR
    Differential suitability of reactive oxygen species and the role of glutathione in regulating paradoxical behavior in gliomas: A mathematical perspective.
    PLoS One. 2020;15:e0235204.
    PubMed     Abstract available


  70. KHOSHNEVIS M, Carozzo C, Brown R, Bardies M, et al
    Feasibility of intratumoral 165Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipig.
    PLoS One. 2020;15:e0234772.
    PubMed     Abstract available


  71. CASANA-ESLAVA RV, Ortega-Martorell S, Lisboa PJ, Candiota AP, et al
    Robust Conditional Independence maps of single-voxel Magnetic Resonance Spectra to elucidate associations between brain tumours and metabolites.
    PLoS One. 2020;15:e0235057.
    PubMed     Abstract available


  72. SHARMA KD, Schaal D, Kore RA, Hamzah RN, et al
    Glioma-derived exosomes drive the differentiation of neural stem cells to astrocytes.
    PLoS One. 2020;15:e0234614.
    PubMed     Abstract available


  73. WALLENBORN M, Xu LX, Kirsten H, Rohani L, et al
    Molecular analyses of glioblastoma stem-like cells and glioblastoma tissue.
    PLoS One. 2020;15:e0234986.
    PubMed     Abstract available


  74. GRONSETH E, Gupta A, Koceja C, Kumar S, et al
    Astrocytes influence medulloblastoma phenotypes and CD133 surface expression.
    PLoS One. 2020;15:e0235852.
    PubMed     Abstract available


  75. HOU X, Yang D, Li D, Liu M, et al
    A new simple brain segmentation method for extracerebral intracranial tumors.
    PLoS One. 2020;15:e0230754.
    PubMed     Abstract available


  76. ZHENG C, Berger NA, Li L, Xu R, et al
    Epigenetic age acceleration and clinical outcomes in gliomas.
    PLoS One. 2020;15:e0236045.
    PubMed     Abstract available


  77. OH SA, Yea JW, Park JW, Park J, et al
    Use of a head-tilting baseplate during volumetric-modulated arc therapy (VMAT) to better protect organs at risk in hippocampal sparing whole brain radiotherapy (HS-WBRT).
    PLoS One. 2020;15:e0232430.
    PubMed     Abstract available


  78. ABDELAZEEM RM, Youssef D, El-Azab J, Hassab-Elnaby S, et al
    Three-dimensional visualization of brain tumor progression based accurate segmentation via comparative holographic projection.
    PLoS One. 2020;15:e0236835.
    PubMed     Abstract available


  79. GARRETT MC, O'Shea TM, Wollenberg AL, Bernstein AM, et al
    Injectable diblock copolypeptide hydrogel provides platform to deliver effective concentrations of paclitaxel to an intracranial xenograft model of glioblastoma.
    PLoS One. 2020;15:e0219632.
    PubMed     Abstract available


  80. CHEN VC, Lin KY, Tsai YH, Weng JC, et al
    Connectome analysis of brain functional network alterations in breast cancer survivors with and without chemotherapy.
    PLoS One. 2020;15:e0232548.
    PubMed     Abstract available


  81. GRAHAM LS, Montgomery B, Cheng HH, Yu EY, et al
    Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies.
    PLoS One. 2020;15:e0233260.
    PubMed     Abstract available


  82. PARKER D, Ould Ismail AA, Wolf R, Brem S, et al
    Freewater estimatoR using iNtErpolated iniTialization (FERNET): Characterizing peritumoral edema using clinically feasible diffusion MRI data.
    PLoS One. 2020;15:e0233645.
    PubMed     Abstract available


  83. KOPER-LENKIEWICZ OM, Kaminska J, Reszec J, Dymicka-Piekarska V, et al
    Elevated plasma 20S proteasome chymotrypsin-like activity is correlated with IL-8 levels and associated with an increased risk of death in glial brain tumor patients.
    PLoS One. 2020;15:e0238406.
    PubMed     Abstract available


  84. LIM SJ, Yeo I, Park CW, Lee H, et al
    Risk factors for osteonecrosis of the femoral head in brain tumor patients receiving corticosteroid after surgery.
    PLoS One. 2020;15:e0238368.
    PubMed     Abstract available


  85. MINEA RO, Duc TC, Swenson SD, Cho HY, et al
    Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas.
    PLoS One. 2020;15:e0238238.
    PubMed     Abstract available


  86. WILHELMY F, Hantsche A, Wende T, Kasper J, et al
    Perioperative anticoagulation in patients with intracranial meningioma: No increased risk of intracranial hemorrhage?
    PLoS One. 2020;15:e0238387.
    PubMed     Abstract available


  87. PRUTEANU LL, Kopanitsa L, Modos D, Kletnieks E, et al
    Transcriptomics predicts compound synergy in drug and natural product treated glioblastoma cells.
    PLoS One. 2020;15:e0239551.
    PubMed     Abstract available


  88. ROSIAK-STEC K, Grot D, Rieske P
    Generation of induced neural stem cells with inducible IDH1R132H for analysis of glioma development and drug testing.
    PLoS One. 2020;15:e0239325.
    PubMed     Abstract available


  89. NUIJTS MA, Veldhuis N, Stegeman I, van Santen HM, et al
    Visual functions in children with craniopharyngioma at diagnosis: A systematic review.
    PLoS One. 2020;15:e0240016.
    PubMed     Abstract available


  90. CRANE AT, Chrostek MR, Krishna VD, Shiao M, et al
    Zika virus-based immunotherapy enhances long-term survival of rodents with brain tumors through upregulation of memory T-cells.
    PLoS One. 2020;15:e0232858.
    PubMed     Abstract available


  91. WENINGER L, Na CH, Jutten K, Merhof D, et al
    Analyzing the effects of free water modeling by deep learning on diffusion MRI structural connectivity estimates in glioma patients.
    PLoS One. 2020;15:e0239475.
    PubMed     Abstract available


  92. CHELEBIAN E, Fuster-Garcia E, Alvarez-Torres MDM, Juan-Albarracin J, et al
    Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype.
    PLoS One. 2020;15:e0232500.
    PubMed     Abstract available


  93. ZHANG J, Li YI, Pieters TA, Towner J, et al
    Sepsis and septic shock after craniotomy: Predicting a significant patient safety and quality outcome measure.
    PLoS One. 2020;15:e0235273.
    PubMed     Abstract available


  94. GUERREIRO EM, Ovstebo R, Thiede B, Costea DE, et al
    Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics.
    PLoS One. 2020;15:e0238591.
    PubMed     Abstract available


  95. TAN TH, Chen D, Soon YY, Chee Seong Tey J, et al
    Quality of reporting of cranial irradiation techniques in randomized controlled trials of primary brain tumors: A systematic review.
    PLoS One. 2020;15:e0241566.
    PubMed     Abstract available


  96. HUANG J, Milchenko M, Rao YJ, LaMontagne P, et al
    A feasibility study to evaluate early treatment response of brain metastases one week after stereotactic radiosurgery using perfusion weighted imaging.
    PLoS One. 2020;15:e0241835.
    PubMed     Abstract available


  97. CHO JH, Lim YC, Han KD, Lee JY, et al
    The incidence of malignant brain tumors is increased in patients with obstructive sleep apnea: A national health insurance survey.
    PLoS One. 2020;15:e0241598.
    PubMed     Abstract available


  98. SAADEH FS, Morsi RZ, El-Kurdi A, Nemer G, et al
    Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population.
    PLoS One. 2020;15:e0242793.
    PubMed     Abstract available


  99. HARATI R, Hafezi S, Mabondzo A, Tlili A, et al
    Silencing miR-202-3p increases MMP-1 and promotes a brain invasive phenotype in metastatic breast cancer cells.
    PLoS One. 2020;15:e0239292.
    PubMed     Abstract available


  100. ACHIHA T, Kijima N, Kodama Y, Kagawa N, et al
    Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion.
    PLoS One. 2020;15:e0243272.
    PubMed     Abstract available


  101. DE MEULENAERE V, Descamps B, De Wever O, Vanhove C, et al
    In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis.
    PLoS One. 2020;15:e0243156.
    PubMed     Abstract available


  102. INHESTERN L, Peikert ML, Krauth KA, Escherich G, et al
    Parents' perception of their children's process of reintegration after childhood cancer treatment.
    PLoS One. 2020;15:e0239967.
    PubMed     Abstract available


  103. KRUSEOVA J, Kovacova AS, Zapotocky M, Sumerauer D, et al
    Older age is a protective factor for academic achievements irrespective of treatment modalities for posterior fossa brain tumours in children.
    PLoS One. 2020;15:e0243998.
    PubMed     Abstract available


  104. TOGAO O, Chikui T, Tokumori K, Kami Y, et al
    Gamma distribution model of diffusion MRI for the differentiation of primary central nerve system lymphomas and glioblastomas.
    PLoS One. 2020;15:e0243839.
    PubMed     Abstract available


  105. CENNAMO G, Solari D, Montorio D, Scala MR, et al
    Early vascular modifications after endoscopic endonasal pituitary surgery: The role of OCT-angiography.
    PLoS One. 2020;15:e0241295.
    PubMed     Abstract available


  106. WU B, Jiang S, Wang X, Zhong S, et al
    Identification of driver genes and key pathways of non-functional pituitary adenomas predicts the therapeutic effect of STO-609.
    PLoS One. 2020;15:e0240230.
    PubMed     Abstract available


  107. WANG JL, Barth RF, Cavaliere R, Puduvalli VK, et al
    Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas.
    PLoS One. 2020;15:e0244383.
    PubMed     Abstract available


  108. DURMO F, Rydhog A, Testud F, Latt J, et al
    Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
    PLoS One. 2020;15:e0244003.
    PubMed     Abstract available


  109. YOUNES ST, Herrington B
    In silico analysis identifies a putative cell-of-origin for BRAF fusion-positive cerebellar pilocytic astrocytoma.
    PLoS One. 2020;15:e0242521.
    PubMed     Abstract available


  110. CHEN T, Ren Y, Wang C, Huang B, et al
    Risk factors for hydrocephalus following fourth ventricle tumor surgery: A retrospective analysis of 121 patients.
    PLoS One. 2020;15:e0241853.
    PubMed     Abstract available


    January 2019
  111. CHEN QF, Huang T, Shen L, Li W, et al
    Predictive value of a nomogram for hepatocellular carcinoma with brain metastasis at initial diagnosis: A population-based study.
    PLoS One. 2019;14:e0209293.
    PubMed     Abstract available


  112. YU X, Dobrikov M, Keir ST, Gromeier M, et al
    Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors.
    PLoS One. 2019;14:e0210608.
    PubMed     Abstract available


  113. SHACKLEFORD GM, Mahdi MY, Moats RA, Hawes D, et al
    Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma.
    PLoS One. 2019;14:e0206394.
    PubMed     Abstract available


  114. LATINI F, Fahlstrom M, Berntsson SG, Larsson EM, et al
    A novel radiological classification system for cerebral gliomas: The Brain-Grid.
    PLoS One. 2019;14:e0211243.
    PubMed     Abstract available


  115. MIRAB F, Kang YJ, Majd S
    Preparation and characterization of size-controlled glioma spheroids using agarose hydrogel microwells.
    PLoS One. 2019;14:e0211078.
    PubMed     Abstract available


  116. ROBSON JP, Remke M, Kool M, Julian E, et al
    Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells.
    PLoS One. 2019;14:e0210665.
    PubMed     Abstract available


  117. VOLNITSKIY A, Shtam T, Burdakov V, Kovalev R, et al
    Abnormal activity of transcription factors gli in high-grade gliomas.
    PLoS One. 2019;14:e0211980.
    PubMed     Abstract available


  118. BENAVIDES-SERRATO A, Lee J, Holmes B, Landon KA, et al
    Correction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
    PLoS One. 2019;14:e0212160.
    PubMed     Abstract available


  119. LANGE F, Wesslau K, Porath K, Hornschemeyer J, et al
    AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.
    PLoS One. 2019;14:e0211644.
    PubMed     Abstract available


  120. CAREY MR, Callaghan BC, Kerber KA, Skolarus LE, et al
    Impact of early headache neuroimaging on time to malignant brain tumor diagnosis: A retrospective cohort study.
    PLoS One. 2019;14:e0211599.
    PubMed     Abstract available


  121. HOHMANN T, Feese K, Ghadban C, Dehghani F, et al
    On the influence of cannabinoids on cell morphology and motility of glioblastoma cells.
    PLoS One. 2019;14:e0212037.
    PubMed     Abstract available


  122. VECERA M, Sana J, Oppelt J, Tichy B, et al
    Testing of library preparation methods for transcriptome sequencing of real life glioblastoma and brain tissue specimens: A comparative study with special focus on long non-coding RNAs.
    PLoS One. 2019;14:e0211978.
    PubMed     Abstract available


  123. ARRIAGADA C, Luchsinger C, Gonzalez AE, Schwenke T, et al
    The knocking down of the oncoprotein Golgi phosphoprotein 3 in T98G cells of glioblastoma multiforme disrupts cell migration by affecting focal adhesion dynamics in a focal adhesion kinase-dependent manner.
    PLoS One. 2019;14:e0212321.
    PubMed     Abstract available


  124. VENTERO MP, Fuentes-Baile M, Quereda C, Perez-Valeciano E, et al
    Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.
    PLoS One. 2019;14:e0212581.
    PubMed     Abstract available


  125. RAKOTONJANAHARY J, Gravier N, Lambron J, De Carli E, et al
    Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy-Analysis of a French pediatric historical cohort.
    PLoS One. 2019;14:e0212107.
    PubMed     Abstract available


  126. ZIMMERMANN M, Rossler K, Kaltenhauser M, Grummich P, et al
    Comparative fMRI and MEG localization of cortical sensorimotor function: Bimodal mapping supports motor area reorganization in glioma patients.
    PLoS One. 2019;14:e0213371.
    PubMed     Abstract available


  127. TANAKA Y, Nakazawa T, Nakamura M, Nishimura F, et al
    Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro.
    PLoS One. 2019;14:e0212455.
    PubMed     Abstract available



  128. Correction: A novel technique of serial biopsy in mouse brain tumour models.
    PLoS One. 2019;14:e0214401.
    PubMed     Abstract available


  129. GRABOWSKA M, Grzeskowiak BF, Szutkowski K, Wawrzyniak D, et al
    Nano-mediated delivery of double-stranded RNA for gene therapy of glioblastoma multiforme.
    PLoS One. 2019;14:e0213852.
    PubMed     Abstract available


  130. WHITE ML, Zhang Y, Yu F, Shonka N, et al
    Post-operative perfusion and diffusion MR imaging and tumor progression in high-grade gliomas.
    PLoS One. 2019;14:e0213905.
    PubMed     Abstract available


  131. JENSEN-KONDERING U, Helle M, Lindner T, Jansen O, et al
    Non-invasive qualitative and semiquantitative presurgical investigation of the feeding vasculature to intracranial meningiomas using superselective arterial spin labeling.
    PLoS One. 2019;14:e0215145.
    PubMed     Abstract available


  132. RYU JA, Jung W, Jung YJ, Kwon DY, et al
    Early prediction of neurological outcome after barbiturate coma therapy in patients undergoing brain tumor surgery.
    PLoS One. 2019;14:e0215280.
    PubMed     Abstract available


  133. VENTERO MP, Fuentes-Baile M, Quereda C, Perez-Valeciano E, et al
    Correction: Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.
    PLoS One. 2019;14:e0215714.
    PubMed     Abstract available


  134. SAINI J, Gupta RK, Kumar M, Singh A, et al
    Comparative evaluation of cerebral gliomas using rCBV measurements during sequential acquisition of T1-perfusion and T2*-perfusion MRI.
    PLoS One. 2019;14:e0215400.
    PubMed     Abstract available


  135. JUNG E, de Los Reyes V AA, Pumares KJA, Kim Y, et al
    Strategies in regulating glioblastoma signaling pathways and anti-invasion therapy.
    PLoS One. 2019;14:e0215547.
    PubMed     Abstract available


  136. YUN PJ, Wang GC, Chen YY, Wu TH, et al
    Brain metastases in resected non-small cell lung cancer: The impact of different tyrosine kinase inhibitors.
    PLoS One. 2019;14:e0215923.
    PubMed     Abstract available


  137. TAKASHIMA Y, Kawaguchi A, Hayano A, Yamanaka R, et al
    CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme.
    PLoS One. 2019;14:e0216825.
    PubMed     Abstract available


  138. INADA M, Shindo M, Kobayashi K, Sato A, et al
    Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells.
    PLoS One. 2019;14:e0216358.
    PubMed     Abstract available


  139. SCHULTEN HJ, Hussein D
    Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas.
    PLoS One. 2019;14:e0215452.
    PubMed     Abstract available


  140. JABLONSKA PA, Diez-Valle R, Perez-Larraya JG, Moreno-Jimenez M, et al
    Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.
    PLoS One. 2019;14:e0217881.
    PubMed     Abstract available


  141. CHOI Y, Ahn KJ, Nam Y, Jang J, et al
    Analysis of peritumoral hyperintensity on pre-operative T2-weighted MR images in glioblastoma: Additive prognostic value of Minkowski functionals.
    PLoS One. 2019;14:e0217785.
    PubMed     Abstract available


  142. NAM MW, Kim JM, Cheong JH, Ryu JI, et al
    Paradoxical relationship between body mass index and bone mineral density in patients with non-small cell lung cancer with brain metastasis.
    PLoS One. 2019;14:e0218825.
    PubMed     Abstract available


  143. CARDONA AF, Ruiz-Patino A, Zatarain-Barron ZL, Hakim F, et al
    Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib.
    PLoS One. 2019;14:e0217340.
    PubMed     Abstract available


  144. OPPERMANN H, Faust H, Yamanishi U, Meixensberger J, et al
    Carnosine inhibits glioblastoma growth independent from PI3K/Akt/mTOR signaling.
    PLoS One. 2019;14:e0218972.
    PubMed     Abstract available


  145. MEANEY C, Stastna M, Kardar M, Kohandel M, et al
    Spatial optimization for radiation therapy of brain tumours.
    PLoS One. 2019;14:e0217354.
    PubMed     Abstract available


  146. JABLONSKA PA, Diez-Valle R, Gallego Perez-Larraya J, Moreno-Jimenez M, et al
    Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.
    PLoS One. 2019;14:e0219614.
    PubMed     Abstract available


  147. FLEISCHMANN DF, Unterrainer M, Corradini S, Rottler M, et al
    Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.
    PLoS One. 2019;14:e0216111.
    PubMed     Abstract available


  148. ZHANG L, Peterson TE, Lu VM, Parney IF, et al
    Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells.
    PLoS One. 2019;14:e0220569.
    PubMed     Abstract available


  149. ORTEGA-MARTORELL S, Candiota AP, Thomson R, Riley P, et al
    Embedding MRI information into MRSI data source extraction improves brain tumour delineation in animal models.
    PLoS One. 2019;14:e0220809.
    PubMed     Abstract available


  150. LAMMER F, Delbridge C, Wurstle S, Neff F, et al
    Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.
    PLoS One. 2019;14:e0221502.
    PubMed     Abstract available


  151. RAVI V, Madhankumar AB, Abraham T, Slagle-Webb B, et al
    Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms.
    PLoS One. 2019;14:e0221952.
    PubMed     Abstract available



  152. Retraction: EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell Growth.
    PLoS One. 2019;14:e0222210.
    PubMed    


  153. SHIVRAM H, Le SV, Iyer VR
    PRC2 activates interferon-stimulated genes indirectly by repressing miRNAs in glioblastoma.
    PLoS One. 2019;14:e0222435.
    PubMed     Abstract available


  154. CHAHAL KK, Li J, Kufareva I, Parle M, et al
    Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma.
    PLoS One. 2019;14:e0214901.
    PubMed     Abstract available


  155. FALTERMEIER C, Chai T, Syed S, Lau N, et al
    Survival of infants </=24 months of age with brain tumors: A population-based study using the SEER database.
    PLoS One. 2019;14:e0223051.
    PubMed     Abstract available


  156. LIU Y, Song C, Shen F, Zhang J, et al
    IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcgammaRIIB phosphorylation in glioblastoma.
    PLoS One. 2019;14:e0222999.
    PubMed     Abstract available


  157. EIJGELAAR R, De Witt Hamer PC, Peeters CFW, Barkhof F, et al
    Voxelwise statistical methods to localize practice variation in brain tumor surgery.
    PLoS One. 2019;14:e0222939.
    PubMed     Abstract available


  158. MITSUYA K, Nakasu Y, Hayashi N, Deguchi S, et al
    Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study.
    PLoS One. 2019;14:e0210074.
    PubMed     Abstract available


  159. ZHENG L, Zhang Y, Hao S, Chen L, et al
    A proteomic clock for malignant gliomas: The role of the environment in tumorigenesis at the presymptomatic stage.
    PLoS One. 2019;14:e0223558.
    PubMed     Abstract available



  160. Retraction: The Different Role of Notch1 and Notch2 in Astrocytic Gliomas.
    PLoS One. 2019;14:e0224117.
    PubMed    


  161. KHAN AU, Mahjabeen I, Malik MA, Hussain MZ, et al
    Modulation of brain tumor risk by genetic SNPs in PARP1gene: Hospital based case control study.
    PLoS One. 2019;14:e0223882.
    PubMed     Abstract available


  162. SATO J, Shimomura A, Kawauchi J, Matsuzaki J, et al
    Brain metastasis-related microRNAs in patients with advanced breast cancer.
    PLoS One. 2019;14:e0221538.
    PubMed     Abstract available


  163. BERENDSEN S, van Bodegraven E, Seute T, Spliet WGM, et al
    Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates.
    PLoS One. 2019;14:e0222717.
    PubMed     Abstract available


  164. FALTERMEIER C, Chai T, Syed S, Lau N, et al
    Correction: Survival of infants </=24 months of age with brain tumors: A population-based study using the SEER database.
    PLoS One. 2019;14:e0224570.
    PubMed     Abstract available


  165. DE MEULENAERE V, Bonte E, Verhoeven J, Kalala Okito JP, et al
    Adjuvant therapeutic potential of tonabersat in the standard treatment of glioblastoma: A preclinical F98 glioblastoma rat model study.
    PLoS One. 2019;14:e0224130.
    PubMed     Abstract available


  166. TAKASHIMA Y, Kawaguchi A, Iwadate Y, Hondoh H, et al
    MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
    PLoS One. 2019;14:e0210400.
    PubMed     Abstract available


  167. PAQUETTE K, Coltin H, Boivin A, Amre D, et al
    Cancer risk in children and young adults born preterm: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0210366.
    PubMed     Abstract available


  168. WANG Q, Perez-Carrillo GJG, Ponisio MR, LaMontagne P, et al
    Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation.
    PLoS One. 2019;14:e0225093.
    PubMed     Abstract available


  169. D'SOUZA S, Ormond DR, Costabile J, Thompson JA, et al
    Fiber-tract localized diffusion coefficients highlight patterns of white matter disruption induced by proximity to glioma.
    PLoS One. 2019;14:e0225323.
    PubMed     Abstract available


  170. CHEN KC, Chen PH, Ho KH, Shih CM, et al
    IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/beta-catenin pathway.
    PLoS One. 2019;14:e0225913.
    PubMed     Abstract available


  171. RYU JY, Min KL, Chang MJ
    Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: A retrospective, single-center study.
    PLoS One. 2019;14:e0225599.
    PubMed     Abstract available


  172. SCOTT SE, Penfold C, Saji S, Curtis S, et al
    'It was nothing that you would think was anything': Qualitative analysis of appraisal and help seeking preceding brain cancer diagnosis.
    PLoS One. 2019;14:e0213599.
    PubMed     Abstract available


  173. SCHULT T, Hauser TK, Klose U, Hurth H, et al
    Fiber visualization for preoperative glioma assessment: Tractography versus local connectivity mapping.
    PLoS One. 2019;14:e0226153.
    PubMed     Abstract available


  174. DATTA K, Lauritzen MH, Merchant M, Jang T, et al
    Reversed metabolic reprogramming as a measure of cancer treatment efficacy in rat C6 glioma model.
    PLoS One. 2019;14:e0225313.
    PubMed     Abstract available


  175. MAITI P, Plemmons A, Dunbar GL
    Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
    PLoS One. 2019;14:e0225660.
    PubMed     Abstract available


  176. BERENS ME, Sood A, Barnholtz-Sloan JS, Graf JF, et al
    Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas.
    PLoS One. 2019;14:e0219724.
    PubMed     Abstract available


  177. ZHAO Z, Wu W, Duan X, Zeng G, et al
    The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases.
    PLoS One. 2019;14:e0215861.
    PubMed     Abstract available


  178. LEE CC, Soon YY, Tan CL, Koh WY, et al
    Discordance of epidermal growth factor receptor mutation between primary lung tumor and paired distant metastases in non-small cell lung cancer: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0218414.
    PubMed     Abstract available


  179. YAMASHITA S, Takeshima H, Matsumoto F, Yamasaki K, et al
    Detection of the KIAA1549-BRAF fusion gene in cells forming microvascular proliferations in pilocytic astrocytoma.
    PLoS One. 2019;14:e0220146.
    PubMed     Abstract available


  180. GOREN L, Zhang G, Kaushik S, Breslin PAS, et al
    (-)-Oleocanthal and (-)-oleocanthal-rich olive oils induce lysosomal membrane permeabilization in cancer cells.
    PLoS One. 2019;14:e0216024.
    PubMed     Abstract available


  181. ZHANG K, Yun SD, Triphan SMF, Sturm VJ, et al
    Vessel architecture imaging using multiband gradient-echo/spin-echo EPI.
    PLoS One. 2019;14:e0220939.
    PubMed     Abstract available


  182. STOJADINOVIC S, Yan Y, Leiker A, Ahn C, et al
    Considerations of target surface area and the risk of radiosurgical toxicity.
    PLoS One. 2019;14:e0224047.
    PubMed     Abstract available


  183. DE REZENDE ACP, Weltman E, Chen MJ, Helito JK, et al
    Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation.
    PLoS One. 2019;14:e0226350.
    PubMed     Abstract available


  184. PODLESEK D, Zolal A, Kirsch M, Schackert G, et al
    Olfactory bulb volume changes associated with trans-sphenoidal pituitary surgery.
    PLoS One. 2019;14:e0224594.
    PubMed     Abstract available


  185. PASTERNAK-PIETRZAK K, Moszczynska E, Roszkowski M, Kot K, et al
    Long-term outcome in patients after treatment for Cushing's disease in childhood.
    PLoS One. 2019;14:e0226033.
    PubMed     Abstract available


    January 2018
  186. SUN G, SiMa G, Wu C, Fan Y, et al
    Decreased MiR-17 in glioma cells increased cell viability and migration by increasing the expression of Cyclin D1, p-Akt and Akt.
    PLoS One. 2018;13:e0190515.
    PubMed     Abstract available


  187. NESKA-MATUSZEWSKA M, Bladowska J, Sasiadek M, Zimny A, et al
    Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
    PLoS One. 2018;13:e0191341.
    PubMed     Abstract available


  188. JONES DC, Scanteianu A, DiStefano M, Bouhaddou M, et al
    Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma.
    PLoS One. 2018;13:e0190664.
    PubMed     Abstract available


  189. BAGHIROV H, Snipstad S, Sulheim E, Berg S, et al
    Ultrasound-mediated delivery and distribution of polymeric nanoparticles in the normal brain parenchyma of a metastatic brain tumour model.
    PLoS One. 2018;13:e0191102.
    PubMed     Abstract available


  190. WILLIAM D, Walther M, Schneider B, Linnebacher M, et al
    Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.
    PLoS One. 2018;13:e0191511.
    PubMed     Abstract available


  191. GARCIA-VILLAESCUSA A, Morales-Tatay JM, Monleon-Salvado D, Gonzalez-Darder JM, et al
    Using NMR in saliva to identify possible biomarkers of glioblastoma and chronic periodontitis.
    PLoS One. 2018;13:e0188710.
    PubMed     Abstract available


  192. CHANG WY, Wu YL, Su PL, Yang SC, et al
    The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.
    PLoS One. 2018;13:e0192161.
    PubMed     Abstract available


  193. LIM WH, Choi SH, Yoo RE, Kang KM, et al
    Does radiation therapy increase gadolinium accumulation in the brain?: Quantitative analysis of T1 shortening using R1 relaxometry in glioblastoma multiforme patients.
    PLoS One. 2018;13:e0192838.
    PubMed     Abstract available


  194. MA C, Nguyen HPT, Luwor RB, Stylli SS, et al
    A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
    PLoS One. 2018;13:e0189452.
    PubMed     Abstract available


  195. MIYAUCHI E, Furuta T, Ohtsuki S, Tachikawa M, et al
    Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics.
    PLoS One. 2018;13:e0193799.
    PubMed     Abstract available


  196. YU KK, Taylor JT, Pathmanaban ON, Youshani AS, et al
    High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma.
    PLoS One. 2018;13:e0193694.
    PubMed     Abstract available


  197. PRESUTTI D, Ceccarelli M, Micheli L, Papoff G, et al
    Tis21-gene therapy inhibits medulloblastoma growth in a murine allograft model.
    PLoS One. 2018;13:e0194206.
    PubMed     Abstract available


  198. HERRERA-PEREZ RM, Voytik-Harbin SL, Sarkaria JN, Pollok KE, et al
    Presence of stromal cells in a bioengineered tumor microenvironment alters glioblastoma migration and response to STAT3 inhibition.
    PLoS One. 2018;13:e0194183.
    PubMed     Abstract available


  199. ZADOR Z, King AT, Geifman N
    New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
    PLoS One. 2018;13:e0194701.
    PubMed     Abstract available


  200. DEIKE-HOFMANN K, Thunemann D, Breckwoldt MO, Schwarz D, et al
    Sensitivity of different MRI sequences in the early detection of melanoma brain metastases.
    PLoS One. 2018;13:e0193946.
    PubMed     Abstract available


  201. MOREAU J, Khalil T, Dupic G, Chautard E, et al
    Second course of stereotactic radiosurgery for locally recurrent brain metastases: Safety and efficacy.
    PLoS One. 2018;13:e0195608.
    PubMed     Abstract available


  202. BERLOW NE, Svalina MN, Quist MJ, Settelmeyer TP, et al
    IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma.
    PLoS One. 2018;13:e0193565.
    PubMed     Abstract available


  203. GE Y, Zhong Y, Ji G, Lu Q, et al
    Preparation and characterization of Fe3O4@Au-C225 composite targeted nanoparticles for MRI of human glioma.
    PLoS One. 2018;13:e0195703.
    PubMed     Abstract available


  204. BLANC-DURAND P, Van Der Gucht A, Schaefer N, Itti E, et al
    Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study.
    PLoS One. 2018;13:e0195798.
    PubMed     Abstract available


  205. AL-SERORI H, Ferk F, Kundi M, Bileck A, et al
    Mobile phone specific electromagnetic fields induce transient DNA damage and nucleotide excision repair in serum-deprived human glioblastoma cells.
    PLoS One. 2018;13:e0193677.
    PubMed     Abstract available


  206. CAPPELLETTI P, Tallarita E, Rabattoni V, Campomenosi P, et al
    Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line.
    PLoS One. 2018;13:e0196283.
    PubMed     Abstract available


  207. LOW SYY, Wei CM, Chang KTE, Huak CY, et al
    Intra-operative cerebrospinal fluid sampling versus post-operative lumbar puncture for detection of leptomeningeal disease in malignant paediatric brain tumours.
    PLoS One. 2018;13:e0196696.
    PubMed     Abstract available


  208. PAN Y, Duron C, Bush EC, Ma Y, et al
    Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.
    PLoS One. 2018;13:e0190001.
    PubMed     Abstract available


  209. MICHAUD K, de Tayrac M, D'Astous M, Paquet C, et al
    Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas.
    PLoS One. 2018;13:e0193213.
    PubMed     Abstract available


  210. HOLSKEN A, Schwarz M, Gillmann C, Pfister C, et al
    Characterization of the murine orthotopic adamantinomatous craniopharyngioma PDX model by MRI in correlation with histology.
    PLoS One. 2018;13:e0197895.
    PubMed     Abstract available


  211. BALERMPAS P, Stera S, Muller von der Grun J, Loutfi-Krauss B, et al
    Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    PLoS One. 2018;13:e0198692.
    PubMed     Abstract available


  212. LIAO WC, Liao CK, Tsai YH, Tseng TJ, et al
    DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
    PLoS One. 2018;13:e0198364.
    PubMed     Abstract available


  213. NGUEMGO KOUAM P, Rezniczek GA, Kochanneck A, Priesch-Grzeszkowiak B, et al
    Robo1 and vimentin regulate radiation-induced motility of human glioblastoma cells.
    PLoS One. 2018;13:e0198508.
    PubMed     Abstract available


  214. RATAI EM, Zhang Z, Fink J, Muzi M, et al
    ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
    PLoS One. 2018;13:e0198548.
    PubMed     Abstract available


  215. BOHN A, Braley A, Rodriguez de la Vega P, Zevallos JC, et al
    The association between race and survival in glioblastoma patients in the US: A retrospective cohort study.
    PLoS One. 2018;13:e0198581.
    PubMed     Abstract available


  216. CHIHARA D, Fanale MA, Miranda RN, Noorani M, et al
    The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.
    PLoS One. 2018;13:e0191461.
    PubMed     Abstract available


  217. BLANC-DURAND P, Van Der Gucht A, Verger A, Langen KJ, et al
    Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas.
    PLoS One. 2018;13:e0199379.
    PubMed     Abstract available


  218. NOWACKA A, Smuczynski W, Rosc D, Wozniak-Dabrowska K, et al
    Serum VEGF-A concentrations in patients with central nervous system (CNS) tumors.
    PLoS One. 2018;13:e0192395.
    PubMed     Abstract available


  219. FABELO H, Ortega S, Ravi D, Kiran BR, et al
    Spatio-spectral classification of hyperspectral images for brain cancer detection during surgical operations.
    PLoS One. 2018;13:e0193721.
    PubMed     Abstract available


  220. MCNEILL RS, Stroobant EE, Smithberger E, Canoutas DA, et al
    PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition.
    PLoS One. 2018;13:e0200014.
    PubMed     Abstract available


  221. SAHIN A, Sanchez C, Bullain S, Waterman P, et al
    Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.
    PLoS One. 2018;13:e0199414.
    PubMed     Abstract available


  222. CONTI S, Vexler A, Edry-Botzer L, Kalich-Philosoph L, et al
    Combined acetyl-11-keto-beta-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
    PLoS One. 2018;13:e0198627.
    PubMed     Abstract available


  223. OKOLIE O, Irvin DM, Bago JR, Sheets K, et al
    Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection.
    PLoS One. 2018;13:e0198596.
    PubMed     Abstract available


  224. HUANG HW, Yan LM, Yang YL, He X, et al
    Bi-frontal pneumocephalus is an independent risk factor for early postoperative agitation in adult patients admitted to intensive care unit after elective craniotomy for brain tumor: A prospective cohort study.
    PLoS One. 2018;13:e0201064.
    PubMed     Abstract available


  225. YOON JS, So CH, Lee HS, Lim JS, et al
    The prevalence of brain abnormalities in boys with central precocious puberty may be overestimated.
    PLoS One. 2018;13:e0195209.
    PubMed     Abstract available


  226. SOUZA TKF, Nucci MP, Mamani JB, da Silva HR, et al
    Image and motor behavior for monitoring tumor growth in C6 glioma model.
    PLoS One. 2018;13:e0201453.
    PubMed     Abstract available


  227. PROTTI A, Jones KL, Bonal DM, Qin L, et al
    Development and validation of a new MRI simulation technique that can reliably estimate optimal in vivo scanning parameters in a glioblastoma murine model.
    PLoS One. 2018;13:e0200611.
    PubMed     Abstract available


  228. PETRELLI F, Lazzari C, Ardito R, Borgonovo K, et al
    Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies.
    PLoS One. 2018;13:e0201425.
    PubMed     Abstract available


  229. GONG S, Zhang F, Norton I, Essayed WI, et al
    Free water modeling of peritumoral edema using multi-fiber tractography: Application to tracking the arcuate fasciculus for neurosurgical planning.
    PLoS One. 2018;13:e0197056.
    PubMed     Abstract available


  230. LIU B, Arakawa Y, Yokogawa R, Tokunaga S, et al
    PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+ and CD8+ infiltrating lymphocytes.
    PLoS One. 2018;13:e0194594.
    PubMed     Abstract available


  231. HAO J, Godley A, Shoemake JD, Han Z, et al
    The effects of extra high dose rate irradiation on glioma stem-like cells.
    PLoS One. 2018;13:e0202533.
    PubMed     Abstract available


  232. ZHAO Z, Yang G, Lin Y, Pang H, et al
    Automated glioma detection and segmentation using graphical models.
    PLoS One. 2018;13:e0200745.
    PubMed     Abstract available


  233. YUAN AL, Ricks CB, Bohm AK, Lun X, et al
    ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts.
    PLoS One. 2018;13:e0202860.
    PubMed     Abstract available


  234. REESE MJ, Knapp DW, Anderson KM, Mund JA, et al
    In vitro effect of chlorambucil on human glioma cell lines (SF767 and U87-MG), and human microvascular endothelial cell (HMVEC) and endothelial progenitor cells (ECFCs), in the context of plasma chlorambucil concentrations in tumor-bearing dogs.
    PLoS One. 2018;13:e0203517.
    PubMed     Abstract available


  235. PARK GHJ, Yang SH, Baek HM
    900MHz 1H-/13C-NMR analysis of 2-hydroxyglutarate and other brain metabolites in human brain tumor tissue extracts.
    PLoS One. 2018;13:e0203379.
    PubMed     Abstract available


  236. GENNATAS ED, Wu A, Braunstein SE, Morin O, et al
    Preoperative and postoperative prediction of long-term meningioma outcomes.
    PLoS One. 2018;13:e0204161.
    PubMed     Abstract available


  237. GARCIA CR, Slone SA, Pittman T, St Clair WH, et al
    Comprehensive evaluation of treatment and outcomes of low-grade diffuse gliomas.
    PLoS One. 2018;13:e0203639.
    PubMed     Abstract available


  238. BROSNAN-CASHMAN JA, Yuan M, Graham MK, Rizzo AJ, et al
    ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner.
    PLoS One. 2018;13:e0204159.
    PubMed     Abstract available



  239. Correction: Glioma IL13Ralpha2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis.
    PLoS One. 2018;13:e0204463.
    PubMed     Abstract available


  240. TIETZE A, Nielsen A, Klaerke Mikkelsen I, Bo Hansen M, et al
    Bayesian modeling of Dynamic Contrast Enhanced MRI data in cerebral glioma patients improves the diagnostic quality of hemodynamic parameter maps.
    PLoS One. 2018;13:e0202906.
    PubMed     Abstract available


  241. ZHANG Z, Wu L, Wang J, Li G, et al
    Correction: Opposing Effects of PI3K/Akt and Smad-Dependent Signaling Pathways in NAG-1-Induced Glioblastoma Cell Apoptosis.
    PLoS One. 2018;13:e0205391.
    PubMed     Abstract available


  242. KIM Y, Kang H, Powathil G, Kim H, et al
    Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma.
    PLoS One. 2018;13:e0204865.
    PubMed     Abstract available


  243. KRESSNER M, Arlt F, Riepl W, Meixensberger J, et al
    Prognostic factors of microsurgical treatment of intracranial meningiomas - A multivariate analysis.
    PLoS One. 2018;13:e0202520.
    PubMed     Abstract available


  244. ARNLI MB, Winther TL, Lydersen S, Torp SH, et al
    Prognostic value of ErbB2/HER2 in human meningiomas.
    PLoS One. 2018;13:e0205846.
    PubMed     Abstract available


  245. FUKUNAGA T, Fujita Y, Kishima H, Yamashita T, et al
    Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma.
    PLoS One. 2018;13:e0206552.
    PubMed     Abstract available


  246. NAMGOONG S, Cheong HS, Kim JH, Kim LH, et al
    Association analysis of RTEL1 variants with risk of adult gliomas in a Korean population.
    PLoS One. 2018;13:e0207660.
    PubMed     Abstract available


  247. LIN MC, Li CZ, Hsieh CC, Hong KT, et al
    Preoperative grading of intracranial meningioma by magnetic resonance spectroscopy (1H-MRS).
    PLoS One. 2018;13:e0207612.
    PubMed     Abstract available


  248. LEITNER J, Pelster S, Schopf V, Berghoff AS, et al
    High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases.
    PLoS One. 2018;13:e0207849.
    PubMed     Abstract available


  249. VAIDYA M, Bacchus M, Sugaya K
    Differential sequences of exosomal NANOG DNA as a potential diagnostic cancer marker.
    PLoS One. 2018;13:e0197782.
    PubMed     Abstract available


  250. SELIGER C, Schaertl J, Gerken M, Luber C, et al
    Use of statins or NSAIDs and survival of patients with high-grade glioma.
    PLoS One. 2018;13:e0207858.
    PubMed     Abstract available


  251. LEUTHARDT EC, Guzman G, Bandt SK, Hacker C, et al
    Integration of resting state functional MRI into clinical practice - A large single institution experience.
    PLoS One. 2018;13:e0198349.
    PubMed     Abstract available


  252. ALLAWAY R, Angus SP, Beauchamp RL, Blakeley JO, et al
    Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.
    PLoS One. 2018;13:e0197350.
    PubMed     Abstract available


  253. WILLIAMS SK, Weiner ZP, Gilmore RD
    Human neuroglial cells internalize Borrelia burgdorferi by coiling phagocytosis mediated by Daam1.
    PLoS One. 2018;13:e0197413.
    PubMed     Abstract available


  254. JUSSILA MP, Remes T, Anttonen J, Harila-Saari A, et al
    Late vertebral side effects in long-term survivors of irradiated childhood brain tumor.
    PLoS One. 2018;13:e0209193.
    PubMed     Abstract available


  255. HINO T, Togao O, Hiwatashi A, Yamashita K, et al
    Clinical efficacy of simplified intravoxel incoherent motion imaging using three b-values for differentiating high- and low-grade gliomas.
    PLoS One. 2018;13:e0209796.
    PubMed     Abstract available


  256. KUNDU S, Cheng Y, Shin M, Manyam G, et al
    Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
    PLoS One. 2018;13:e0195070.
    PubMed     Abstract available


  257. GARCIA-MARTINEZ A, Sottile J, Fajardo C, Riesgo P, et al
    Is it time to consider the expression of specific-pituitary hormone genes when typifying pituitary tumours?
    PLoS One. 2018;13:e0198877.
    PubMed     Abstract available


  258. MORETTI IF, Franco DG, de Almeida Galatro TF, Oba-Shinjo SM, et al
    Plasmatic membrane toll-like receptor expressions in human astrocytomas.
    PLoS One. 2018;13:e0199211.
    PubMed     Abstract available


  259. KORSHOEJ AR, Hansen FL, Mikic N, von Oettingen G, et al
    Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations.
    PLoS One. 2018;13:e0201957.
    PubMed     Abstract available


  260. CHEN J
    The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis.
    PLoS One. 2018;13:e0200909.
    PubMed     Abstract available


  261. YOON RG, Kim HS, Hong GS, Park JE, et al
    Joint approach of diffusion- and perfusion-weighted MRI in intra-axial mass like lesions in clinical practice simulation.
    PLoS One. 2018;13:e0202891.
    PubMed     Abstract available


  262. LUHTALA N, Hunter T
    Failure to detect functional transfer of active K-Ras protein from extracellular vesicles into recipient cells in culture.
    PLoS One. 2018;13:e0203290.
    PubMed     Abstract available


  263. BERTERO L, Anfossi V, Osella-Abate S, Disanto MG, et al
    Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series.
    PLoS One. 2018;13:e0203570.
    PubMed     Abstract available


  264. DENNISON KL, Chack AC, Hickman MP, Harenda QE, et al
    Ept7, a quantitative trait locus that controls estrogen-induced pituitary lactotroph hyperplasia in rat, is orthologous to a locus in humans that has been associated with numerous cancer types and common diseases.
    PLoS One. 2018;13:e0204727.
    PubMed     Abstract available


  265. RICHTIG G, Hoeller C, Wolf M, Wolf I, et al
    Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study.
    PLoS One. 2018;13:e0204729.
    PubMed     Abstract available


  266. NEUMANN JO, Campos B, Younes B, Jakobs M, et al
    Frame-based stereotactic biopsies using an intraoperative MR-scanner are as safe and effective as conventional stereotactic procedures.
    PLoS One. 2018;13:e0205772.
    PubMed     Abstract available


  267. PERDOMO-PANTOJA A, Mejia-Perez SI, Reynoso-Noveron N, Gomez-Flores-Ramos L, et al
    Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma.
    PLoS One. 2018;13:e0206590.
    PubMed     Abstract available


  268. DE MEULENAERE V, Neyt S, Vandeghinste B, Mollet P, et al
    Species-dependent extracranial manifestations of a brain seeking breast cancer cell line.
    PLoS One. 2018;13:e0208340.
    PubMed     Abstract available


    January 2017
  269. HENNIKA T, Hu G, Olaciregui NG, Barton KL, et al
    Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models.
    PLoS One. 2017;12:e0169485.
    PubMed     Abstract available


  270. JONES JE, Esler WP, Patel R, Lanba A, et al
    Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells.
    PLoS One. 2017;12:e0169566.
    PubMed     Abstract available


  271. CILIBRASI C, Riva G, Romano G, Cadamuro M, et al
    Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway.
    PLoS One. 2017;12:e0169854.
    PubMed     Abstract available


  272. QIN H, Janowski M, Pearl MS, Malysz-Cymborska I, et al
    Rabbit Model of Human Gliomas: Implications for Intra-Arterial Drug Delivery.
    PLoS One. 2017;12:e0169656.
    PubMed     Abstract available


  273. EIDEL O, Burth S, Neumann JO, Kieslich PJ, et al
    Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology.
    PLoS One. 2017;12:e0169292.
    PubMed     Abstract available


  274. ESTEVE-CODINA A, Arpi O, Martinez-Garcia M, Pineda E, et al
    A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples.
    PLoS One. 2017;12:e0170632.
    PubMed     Abstract available


  275. DOMENIS R, Cesselli D, Toffoletto B, Bourkoula E, et al
    Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells.
    PLoS One. 2017;12:e0169932.
    PubMed     Abstract available


  276. LIU PC, Lu G, Deng Y, Wang CD, et al
    Inhibition of NF-kappaB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy.
    PLoS One. 2017;12:e0171157.
    PubMed     Abstract available


  277. LEE W, Lim S, Kim Y
    The role of myosin II in glioma invasion: A mathematical model.
    PLoS One. 2017;12:e0171312.
    PubMed     Abstract available


  278. HSIEH KL, Tsai RJ, Teng YC, Lo CM, et al
    Effect of a computer-aided diagnosis system on radiologists' performance in grading gliomas with MRI.
    PLoS One. 2017;12:e0171342.
    PubMed     Abstract available


  279. CHLAPEK P, Zitterbart K, Kren L, Filipova L, et al
    Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups.
    PLoS One. 2017;12:e0172552.
    PubMed     Abstract available


  280. HUBER T, Alber G, Bette S, Kaesmacher J, et al
    Progressive disease in glioblastoma: Benefits and limitations of semi-automated volumetry.
    PLoS One. 2017;12:e0173112.
    PubMed     Abstract available


  281. BROWN DV, Filiz G, Daniel PM, Hollande F, et al
    Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
    PLoS One. 2017;12:e0172791.
    PubMed     Abstract available


  282. POLLAK J, Rai KG, Funk CC, Arora S, et al
    Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.
    PLoS One. 2017;12:e0172884.
    PubMed     Abstract available


  283. WINTHER TL, Torp SH
    DNA topoisomerase IIalpha and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery.
    PLoS One. 2017;12:e0172316.
    PubMed     Abstract available


  284. XU W, Wang Q, Shao A, Xu B, et al
    The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0173430.
    PubMed     Abstract available


  285. JIA P, Li F, Gu W, Zhang W, et al
    Gab3 overexpression in human glioma mediates Akt activation and tumor cell proliferation.
    PLoS One. 2017;12:e0173473.
    PubMed     Abstract available


  286. KAYA B, Goceri E, Becker A, Elder B, et al
    Automated fluorescent miscroscopic image analysis of PTBP1 expression in glioma.
    PLoS One. 2017;12:e0170991.
    PubMed     Abstract available


  287. LEE CC, Chen PH, Ho KH, Shih CM, et al
    The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA.
    PLoS One. 2017;12:e0173890.
    PubMed     Abstract available


  288. CONNOLLY NP, Stokum JA, Schneider CS, Ozawa T, et al
    Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer.
    PLoS One. 2017;12:e0174557.
    PubMed     Abstract available


  289. SHERRY-LYNES MM, Sengupta S, Kulkarni S, Cochran BH, et al
    Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3.
    PLoS One. 2017;12:e0174775.
    PubMed     Abstract available


  290. HSU SY, Ou CY, Ho YN, Huang YH, et al
    Application of Surgical Apgar Score in intracranial meningioma surgery.
    PLoS One. 2017;12:e0174328.
    PubMed     Abstract available


  291. REIMER C, Deike K, Graf M, Reimer P, et al
    Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps.
    PLoS One. 2017;12:e0174620.
    PubMed     Abstract available


  292. ROGERS S, Hii H, Huang J, Ancliffe M, et al
    A novel technique of serial biopsy in mouse brain tumour models.
    PLoS One. 2017;12:e0175169.
    PubMed     Abstract available


  293. YANG L, Mu Y, Cui H, Liang Y, et al
    MiR-9-3p augments apoptosis induced by H2O2 through down regulation of Herpud1 in glioma.
    PLoS One. 2017;12:e0174839.
    PubMed     Abstract available


  294. SUN L, Moritake T, Ito K, Matsumoto Y, et al
    Metabolic analysis of radioresistant medulloblastoma stem-like clones and potential therapeutic targets.
    PLoS One. 2017;12:e0176162.
    PubMed     Abstract available


  295. MERCURIO L, Cecchetti S, Ricci A, Pacella A, et al
    Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells.
    PLoS One. 2017;12:e0176108.
    PubMed     Abstract available


  296. SANCHEZ-DIAZ PC, Chang JC, Moses ES, Dao T, et al
    Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is associated with stem-like cancer cell functions in pediatric high-grade glioma.
    PLoS One. 2017;12:e0176879.
    PubMed     Abstract available


  297. YANG M, Guo W, Yang C, Tang J, et al
    Mobile phone use and glioma risk: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0175136.
    PubMed     Abstract available


  298. HILL VK, Kim JS, James CD, Waldman T, et al
    Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing.
    PLoS One. 2017;12:e0176683.
    PubMed     Abstract available


  299. ERMINI L, Morganti E, Post A, Yeganeh B, et al
    Imaging mass spectrometry identifies prognostic ganglioside species in rodent intracranial transplants of glioma and medulloblastoma.
    PLoS One. 2017;12:e0176254.
    PubMed     Abstract available


  300. BENAVIDES-SERRATO A, Lee J, Holmes B, Landon KA, et al
    Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
    PLoS One. 2017;12:e0176599.
    PubMed     Abstract available


  301. RAUSCHERT I, Aldunate F, Preussner J, Arocena-Sutz M, et al
    Promoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells.
    PLoS One. 2017;12:e0175953.
    PubMed     Abstract available


  302. HOWE JR 6TH, Li ES, Streeter SE, Rahme GJ, et al
    MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation.
    PLoS One. 2017;12:e0177661.
    PubMed     Abstract available


  303. PETUSHKOVA NA, Zgoda VG, Pyatnitskiy MA, Larina OV, et al
    Post-translational modifications of FDA-approved plasma biomarkers in glioblastoma samples.
    PLoS One. 2017;12:e0177427.
    PubMed     Abstract available


  304. SCHNEIDER T, Kuhne JF, Bittrich P, Schroeder J, et al
    Edema is not a reliable diagnostic sign to exclude small brain metastases.
    PLoS One. 2017;12:e0177217.
    PubMed     Abstract available


  305. BOOTH TC, Larkin TJ, Yuan Y, Kettunen MI, et al
    Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.
    PLoS One. 2017;12:e0176528.
    PubMed     Abstract available


  306. BLYSTAD I, Warntjes JBM, Smedby O, Lundberg P, et al
    Quantitative MRI for analysis of peritumoral edema in malignant gliomas.
    PLoS One. 2017;12:e0177135.
    PubMed     Abstract available


  307. MCDONALD JT, Gao X, Steber C, Lee Breed J, et al
    Host mediated inflammatory influence on glioblastoma multiforme recurrence following high-dose ionizing radiation.
    PLoS One. 2017;12:e0178155.
    PubMed     Abstract available


  308. KILLICK-COLE CL, Singleton WGB, Bienemann AS, Asby DJ, et al
    Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma.
    PLoS One. 2017;12:e0176855.
    PubMed     Abstract available


  309. WEI KC, Chen CY, Feng LY, Huang WT, et al
    The rs16906252:C>T SNP is not associated with increased overall survival or temozolomide response in a Han-Chinese glioma cohort.
    PLoS One. 2017;12:e0178842.
    PubMed     Abstract available


  310. HENARES-MOLINA A, Benzekry S, Lara PC, Garcia-Rojo M, et al
    Non-standard radiotherapy fractionations delay the time to malignant transformation of low-grade gliomas.
    PLoS One. 2017;12:e0178552.
    PubMed     Abstract available


  311. KUTWIN M, Sawosz E, Jaworski S, Wierzbicki M, et al
    Assessment of the proliferation status of glioblastoma cell and tumour tissue after nanoplatinum treatment.
    PLoS One. 2017;12:e0178277.
    PubMed     Abstract available


  312. MEI Y, Bi WL, Greenwald NF, Agar NY, et al
    Genomic profile of human meningioma cell lines.
    PLoS One. 2017;12:e0178322.
    PubMed     Abstract available


  313. SCHWARTZBAUM J, Wang M, Root E, Pietrzak M, et al
    A nested case-control study of 277 prediagnostic serum cytokines and glioma.
    PLoS One. 2017;12:e0178705.
    PubMed     Abstract available


  314. SUNWOO L, Kim YJ, Choi SH, Kim KG, et al
    Computer-aided detection of brain metastasis on 3D MR imaging: Observer performance study.
    PLoS One. 2017;12:e0178265.
    PubMed     Abstract available


  315. YANG CF, Ho HL, Lin SC, Hsu CY, et al
    Detection of human cytomegalovirus in glioblastoma among Taiwanese subjects.
    PLoS One. 2017;12:e0179366.
    PubMed     Abstract available


  316. MOLINA D, Perez-Beteta J, Martinez-Gonzalez A, Martino J, et al
    Lack of robustness of textural measures obtained from 3D brain tumor MRIs impose a need for standardization.
    PLoS One. 2017;12:e0178843.
    PubMed     Abstract available


  317. STEWART DC, Rubiano A, Dyson K, Simmons CS, et al
    Mechanical characterization of human brain tumors from patients and comparison to potential surgical phantoms.
    PLoS One. 2017;12:e0177561.
    PubMed     Abstract available


  318. WARD NP, Poff AM, Koutnik AP, D'Agostino DP, et al
    Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells.
    PLoS One. 2017;12:e0180061.
    PubMed     Abstract available


  319. KUMAR R, de Mooij T, Peterson TE, Kaptzan T, et al
    Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane.
    PLoS One. 2017;12:e0179012.
    PubMed     Abstract available


  320. ZHAO P, Hall J, Durston M, Voydanoff A, et al
    BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma.
    PLoS One. 2017;12:e0179948.
    PubMed     Abstract available


  321. LEE JC, Chuang KS, Chen YW, Hsu FY, et al
    Preliminary dosimetric study on feasibility of multi-beam boron neutron capture therapy in patients with diffuse intrinsic pontine glioma without craniotomy.
    PLoS One. 2017;12:e0180461.
    PubMed     Abstract available


  322. FOSMARK S, Hellwege S, Dahlrot RH, Jensen KL, et al
    APNG as a prognostic marker in patients with glioblastoma.
    PLoS One. 2017;12:e0178693.
    PubMed     Abstract available


  323. KESSEL KA, Hesse J, Straube C, Zimmer C, et al
    Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma.
    PLoS One. 2017;12:e0180457.
    PubMed     Abstract available


  324. SELIGER C, Meier CR, Becker C, Jick SS, et al
    Diabetes, use of metformin, and the risk of meningioma.
    PLoS One. 2017;12:e0181089.
    PubMed     Abstract available


  325. AL-SAFFAR NMS, Agliano A, Marshall LV, Jackson LE, et al
    In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells.
    PLoS One. 2017;12:e0180263.
    PubMed     Abstract available


  326. MASCHIO M, Beghi E, Casazza MML, Colicchio G, et al
    Patterns of care of brain tumor-related epilepsy. A cohort study done in Italian Epilepsy Center.
    PLoS One. 2017;12:e0180470.
    PubMed     Abstract available


  327. ZEH R, Sheikh S, Xia L, Pierce J, et al
    The second window ICG technique demonstrates a broad plateau period for near infrared fluorescence tumor contrast in glioblastoma.
    PLoS One. 2017;12:e0182034.
    PubMed     Abstract available


  328. PARK JE, Ryu KH, Kim HS, Kim HW, et al
    Perfusion of surgical cavity wall enhancement in early post-treatment MR imaging may stratify the time-to-progression in glioblastoma.
    PLoS One. 2017;12:e0181933.
    PubMed     Abstract available


  329. CHEN J, Mao S, Li H, Zheng M, et al
    The pathological structure of the perivascular niche in different microvascular patterns of glioblastoma.
    PLoS One. 2017;12:e0182183.
    PubMed     Abstract available


  330. BOGDANSKA MU, Bodnar M, Piotrowska MJ, Murek M, et al
    A mathematical model describes the malignant transformation of low grade gliomas: Prognostic implications.
    PLoS One. 2017;12:e0179999.
    PubMed     Abstract available


  331. FISHER CJ, Niu C, Foltz W, Chen Y, et al
    ALA-PpIX mediated photodynamic therapy of malignant gliomas augmented by hypothermia.
    PLoS One. 2017;12:e0181654.
    PubMed     Abstract available


  332. GLADILIN E
    Graph-theoretical model of global human interactome reveals enhanced long-range communicability in cancer networks.
    PLoS One. 2017;12:e0170953.
    PubMed     Abstract available


  333. MALCHENKO S, Sredni ST, Bi Y, Margaryan NV, et al
    Stabilization of HIF-1alpha and HIF-2alpha, up-regulation of MYCC and accumulation of stabilized p53 constitute hallmarks of CNS-PNET animal model.
    PLoS One. 2017;12:e0173106.
    PubMed     Abstract available


  334. CHIBA R, Akiya M, Hashimura M, Oguri Y, et al
    ALK signaling cascade confers multiple advantages to glioblastoma cells through neovascularization and cell proliferation.
    PLoS One. 2017;12:e0183516.
    PubMed     Abstract available


  335. ROSAGER AM, Sorensen MD, Dahlrot RH, Hansen S, et al
    Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
    PLoS One. 2017;12:e0182954.
    PubMed     Abstract available


  336. GAO L, Chen B, Li J, Yang F, et al
    Wnt/beta-catenin signaling pathway inhibits the proliferation and apoptosis of U87 glioma cells via different mechanisms.
    PLoS One. 2017;12:e0181346.
    PubMed     Abstract available


  337. GAO B, Shen X, Shiroishi MS, Pang M, et al
    A pilot study of pre-operative motor dysfunction from gliomas in the region of corticospinal tract: Evaluation with diffusion tensor imaging.
    PLoS One. 2017;12:e0182795.
    PubMed     Abstract available


  338. RAMIS R, Tamayo-Uria I, Gomez-Barroso D, Lopez-Abente G, et al
    Risk factors for central nervous system tumors in children: New findings from a case-control study.
    PLoS One. 2017;12:e0171881.
    PubMed     Abstract available


  339. MARIGIL M, Martinez-Velez N, Dominguez PD, Idoate MA, et al
    Development of a DIPG Orthotopic Model in Mice Using an Implantable Guide-Screw System.
    PLoS One. 2017;12:e0170501.
    PubMed     Abstract available


  340. SCRIBNER E, Fathallah-Shaykh HM
    Single Cell Mathematical Model Successfully Replicates Key Features of GBM: Go-Or-Grow Is Not Necessary.
    PLoS One. 2017;12:e0169434.
    PubMed     Abstract available


  341. SAUWEN N, Acou M, Bharath HN, Sima DM, et al
    The successive projection algorithm as an initialization method for brain tumor segmentation using non-negative matrix factorization.
    PLoS One. 2017;12:e0180268.
    PubMed     Abstract available


  342. KIVINIEMI V, Korhonen V, Kortelainen J, Rytky S, et al
    Real-time monitoring of human blood-brain barrier disruption.
    PLoS One. 2017;12:e0174072.
    PubMed     Abstract available


  343. GOODS BA, Hernandez AL, Lowther DE, Lucca LE, et al
    Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme.
    PLoS One. 2017;12:e0181538.
    PubMed     Abstract available


  344. FORNVIK K, Maddahi A, Persson O, Osther K, et al
    C1-inactivator is upregulated in glioblastoma.
    PLoS One. 2017;12:e0183086.
    PubMed     Abstract available


  345. CHENG B, Morales LD, Zhang Y, Mito S, et al
    Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line.
    PLoS One. 2017;12:e0184324.
    PubMed     Abstract available


  346. FELDMAN LA, Fabre MS, Grasso C, Reid D, et al
    Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas.
    PLoS One. 2017;12:e0184250.
    PubMed     Abstract available


  347. WERNECK DE CARVALHO LE, Sarraf JS, Semblano AA, Moreira MA, et al
    Central nervous system tumours profile at a referral center in the Brazilian Amazon region, 1997-2014.
    PLoS One. 2017;12:e0174439.
    PubMed     Abstract available


  348. RAMACHANDRAN RK, Sorensen MD, Aaberg-Jessen C, Hermansen SK, et al
    Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.
    PLoS One. 2017;12:e0172234.
    PubMed     Abstract available


  349. SCHAEFER S, Svenstrup TH, Guerra B
    The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells.
    PLoS One. 2017;12:e0177706.
    PubMed     Abstract available


  350. WILLIAM D, Mokri P, Lamp N, Linnebacher M, et al
    Amplification of the EGFR gene can be maintained and modulated by variation of EGF concentrations in in vitro models of glioblastoma multiforme.
    PLoS One. 2017;12:e0185208.
    PubMed     Abstract available


  351. WANG ZQ, Zhang MY, Deng ML, Weng NQ, et al
    Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    PLoS One. 2017;12:e0184969.
    PubMed     Abstract available


  352. SUN M, Zhang Z, Ma C, Chen S, et al
    Quantitative analysis of retinal layers on three-dimensional spectral-domain optical coherence tomography for pituitary adenoma.
    PLoS One. 2017;12:e0179532.
    PubMed     Abstract available


  353. BECHER OJ, Millard NE, Modak S, Kushner BH, et al
    A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
    PLoS One. 2017;12:e0178593.
    PubMed     Abstract available


  354. WINTHER TL, Torp SH
    The anti-apoptotic protein survivin can improve the prognostication of meningioma patients.
    PLoS One. 2017;12:e0185217.
    PubMed     Abstract available


  355. EUSKIRCHEN P, Radke J, Schmidt MS, Schulze Heuling E, et al
    Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma.
    PLoS One. 2017;12:e0185376.
    PubMed     Abstract available


  356. KWIATKOWSKI SC, Guerrero PA, Hirota S, Chen Z, et al
    Neuropilin-1 modulates TGFbeta signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy.
    PLoS One. 2017;12:e0185065.
    PubMed     Abstract available


  357. DADONE-MONTAUDIE B, Ambrosetti D, Dufour M, Darcourt J, et al
    [18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression.
    PLoS One. 2017;12:e0184625.
    PubMed     Abstract available


  358. ISAEVSKA E, Manasievska M, Alessi D, Mosso ML, et al
    Cancer incidence rates and trends among children and adolescents in Piedmont, 1967-2011.
    PLoS One. 2017;12:e0181805.
    PubMed     Abstract available


  359. REICHERT JL, Chocholous M, Leiss U, Pletschko T, et al
    Neuronal correlates of cognitive function in patients with childhood cerebellar tumor lesions.
    PLoS One. 2017;12:e0180200.
    PubMed     Abstract available


  360. SANCHEZ-TEJADA L, Sanchez-Ortiga R, Lamas C, Camara R, et al
    Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas.
    PLoS One. 2017;12:e0180039.
    PubMed     Abstract available


  361. KORSHOEJ AR, Hansen FL, Thielscher A, von Oettingen GB, et al
    Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study.
    PLoS One. 2017;12:e0179214.
    PubMed     Abstract available


  362. LIU Y, Stojadinovic S, Hrycushko B, Wardak Z, et al
    A deep convolutional neural network-based automatic delineation strategy for multiple brain metastases stereotactic radiosurgery.
    PLoS One. 2017;12:e0185844.
    PubMed     Abstract available


  363. HARDELL L, Carlberg M
    Mobile phones, cordless phones and rates of brain tumors in different age groups in the Swedish National Inpatient Register and the Swedish Cancer Register during 1998-2015.
    PLoS One. 2017;12:e0185461.
    PubMed     Abstract available


  364. GARCIA-RECIO M, Cladera A, Bento L, Dominguez J, et al
    Analysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experience.
    PLoS One. 2017;12:e0179595.
    PubMed     Abstract available


  365. OH SA, Park JW, Yea JW, Kim SK, et al
    Evaluations of the setup discrepancy between BrainLAB 6D ExacTrac and cone-beam computed tomography used with the imaging guidance system Novalis-Tx for intracranial stereotactic radiosurgery.
    PLoS One. 2017;12:e0177798.
    PubMed     Abstract available


  366. MELEIS AM, Mahtabfar A, Danish S, Foty RA, et al
    Dexamethasone-mediated inhibition of Glioblastoma neurosphere dispersal in an ex vivo organotypic neural assay.
    PLoS One. 2017;12:e0186483.
    PubMed     Abstract available


  367. HSU CY, Ho HL, Lin SC, Ho TD, et al
    The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.
    PLoS One. 2017;12:e0186430.
    PubMed     Abstract available


  368. KIM SW, Shin HJ, Hwang JH, Shin JS, et al
    Image similarity evaluation of the bulk-density-assigned synthetic CT derived from MRI of intracranial regions for radiation treatment.
    PLoS One. 2017;12:e0185082.
    PubMed     Abstract available


  369. LEE JY, Park JE, Kim HS, Kim SO, et al
    Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients.
    PLoS One. 2017;12:e0183916.
    PubMed     Abstract available


  370. PRABHU VV, Lulla AR, Madhukar NS, Ralff MD, et al
    Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
    PLoS One. 2017;12:e0180541.
    PubMed     Abstract available


  371. MITRA S, Banerjee S, Hayashi Y
    Volumetric brain tumour detection from MRI using visual saliency.
    PLoS One. 2017;12:e0187209.
    PubMed     Abstract available


  372. GRENIER JK, Foureman PA, Sloma EA, Miller AD, et al
    RNA-seq transcriptome analysis of formalin fixed, paraffin-embedded canine meningioma.
    PLoS One. 2017;12:e0187150.
    PubMed     Abstract available


  373. MADHU B, Jauhiainen A, McGuire S, Griffiths JR, et al
    Exploration of human brain tumour metabolism using pairwise metabolite-metabolite correlation analysis (MMCA) of HR-MAS 1H NMR spectra.
    PLoS One. 2017;12:e0185980.
    PubMed     Abstract available


  374. FAN W, Fan SS, Feng J, Xiao D, et al
    Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma.
    PLoS One. 2017;12:e0185563.
    PubMed     Abstract available


  375. COROLLER TP, Bi WL, Huynh E, Abedalthagafi M, et al
    Radiographic prediction of meningioma grade by semantic and radiomic features.
    PLoS One. 2017;12:e0187908.
    PubMed     Abstract available


  376. HERMANSEN SK, Sorensen MD, Hansen A, Knudsen S, et al
    A 4-miRNA signature to predict survival in glioblastomas.
    PLoS One. 2017;12:e0188090.
    PubMed     Abstract available


  377. OH J, Kim Y, Che L, Kim JB, et al
    Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma.
    PLoS One. 2017;12:e0178881.
    PubMed     Abstract available


  378. KYEONG S, Cha YJ, Ahn SG, Suh SH, et al
    Subtypes of breast cancer show different spatial distributions of brain metastases.
    PLoS One. 2017;12:e0188542.
    PubMed     Abstract available


  379. LIU H, Liu N, Cheng Y, Jin W, et al
    Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathway.
    PLoS One. 2017;12:e0189353.
    PubMed     Abstract available


  380. JENSEN KV, Cseh O, Aman A, Weiss S, et al
    The JAK2/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft model.
    PLoS One. 2017;12:e0189670.
    PubMed     Abstract available


  381. ZETTERLING M, Berhane L, Alafuzoff I, Jakola AS, et al
    Prognostic markers for survival in patients with oligodendroglial tumors; a single-institution review of 214 cases.
    PLoS One. 2017;12:e0188419.
    PubMed     Abstract available


  382. LEE JY, Park JE, Shim WH, Jung SC, et al
    Joint approach based on clinical and imaging features to distinguish non-neoplastic from neoplastic pituitary stalk lesions.
    PLoS One. 2017;12:e0187989.
    PubMed     Abstract available


    January 2016
  383. KO CC, Tai MH, Li CF, Chen TY, et al
    Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.
    PLoS One. 2016;11:e0162565.
    PubMed     Abstract available


  384. JARMUSCH AK, Alfaro CM, Pirro V, Hattab EM, et al
    Differential Lipid Profiles of Normal Human Brain Matter and Gliomas by Positive and Negative Mode Desorption Electrospray Ionization - Mass Spectrometry Imaging.
    PLoS One. 2016;11:e0163180.
    PubMed     Abstract available


  385. MIN W, Dai D, Wang J, Zhang D, et al
    Long Noncoding RNA miR210HG as a Potential Biomarker for the Diagnosis of Glioma.
    PLoS One. 2016;11:e0160451.
    PubMed     Abstract available


  386. KINOSHITA M, Sakai M, Arita H, Shofuda T, et al
    Introduction of High Throughput Magnetic Resonance T2-Weighted Image Texture Analysis for WHO Grade 2 and 3 Gliomas.
    PLoS One. 2016;11:e0164268.
    PubMed     Abstract available


  387. YE H, Huang H, Cao F, Chen M, et al
    HSPB1 Enhances SIRT2-Mediated G6PD Activation and Promotes Glioma Cell Proliferation.
    PLoS One. 2016;11:e0164285.
    PubMed     Abstract available


  388. HICKS MJ, Chiuchiolo MJ, Ballon D, Dyke JP, et al
    Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma.
    PLoS One. 2016;11:e0162978.
    PubMed     Abstract available


  389. KORSHOEJ AR, Saturnino GB, Rasmussen LK, von Oettingen G, et al
    Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study.
    PLoS One. 2016;11:e0164051.
    PubMed     Abstract available


  390. BOLCAEN J, Lybaert K, Moerman L, Descamps B, et al
    Correction: Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.
    PLoS One. 2016;11:e0164208.
    PubMed     Abstract available


  391. SAGARA A, Igarashi K, Otsuka M, Karasawa T, et al
    Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR.
    PLoS One. 2016;11:e0164250.
    PubMed     Abstract available


  392. YE R, Shen T, Jiang Y, Xu L, et al
    The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis.
    PLoS One. 2016;11:e0164388.
    PubMed     Abstract available


  393. FREITAG MT, Maier-Hein KH, Binczyk F, Laun FB, et al
    Early Detection of Malignant Transformation in Resected WHO II Low-Grade Glioma Using Diffusion Tensor-Derived Quantitative Measures.
    PLoS One. 2016;11:e0164679.
    PubMed     Abstract available


  394. LEMAIRE L, Nel J, Franconi F, Bastiat G, et al
    Perfluorocarbon-Loaded Lipid Nanocapsules to Assess the Dependence of U87-Human Glioblastoma Tumor pO2 on In Vitro Expansion Conditions.
    PLoS One. 2016;11:e0165479.
    PubMed     Abstract available


  395. SUFIT A, Lee-Sherick AB, DeRyckere D, Rupji M, et al
    MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme.
    PLoS One. 2016;11:e0165107.
    PubMed     Abstract available


  396. FYLLINGEN EH, Stensjoen AL, Berntsen EM, Solheim O, et al
    Glioblastoma Segmentation: Comparison of Three Different Software Packages.
    PLoS One. 2016;11:e0164891.
    PubMed     Abstract available


  397. DAHLIN AM, Wibom C, Ghasimi S, Brannstrom T, et al
    Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor.
    PLoS One. 2016;11:e0163067.
    PubMed     Abstract available


  398. LUM MA, Martin AJ, Alexander MD, McCoy DB, et al
    Intra-Arterial MR Perfusion Imaging of Meningiomas: Comparison to Digital Subtraction Angiography and Intravenous MR Perfusion Imaging.
    PLoS One. 2016;11:e0163554.
    PubMed     Abstract available


  399. JANISZEWSKA J, Posadas I, Jativa P, Bugaj-Zarebska M, et al
    Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or Astrocytes.
    PLoS One. 2016;11:e0165704.
    PubMed     Abstract available


  400. KIRSCHNER S, Murle B, Felix M, Arns A, et al
    Imaging of Orthotopic Glioblastoma Xenografts in Mice Using a Clinical CT Scanner: Comparison with Micro-CT and Histology.
    PLoS One. 2016;11:e0165994.
    PubMed     Abstract available


  401. MARTINEZ NJ, Rai G, Yasgar A, Lea WA, et al
    Correction: A High-Throughput Screen Identifies 2,9-Diazaspiro[5.5]Undecanes as Inducers of the Endoplasmic Reticulum Stress Response with Cytotoxic Activity in 3D Glioma Cell Models.
    PLoS One. 2016;11:e0166506.
    PubMed     Abstract available


  402. CRISMAN TJ, Zelaya I, Laks DR, Zhao Y, et al
    Identification of an Efficient Gene Expression Panel for Glioblastoma Classification.
    PLoS One. 2016;11:e0164649.
    PubMed     Abstract available


  403. KIM BR, Choi SH, Yun TJ, Lee ST, et al
    MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction.
    PLoS One. 2016;11:e0166096.
    PubMed     Abstract available


  404. SUNWOO L, Yun TJ, You SH, Yoo RE, et al
    Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR Imaging.
    PLoS One. 2016;11:e0166662.
    PubMed     Abstract available


  405. DEUSCHL C, Goericke S, Grueneisen J, Sawicki LM, et al
    Simultaneous 11C-Methionine Positron Emission Tomography/Magnetic Resonance Imaging of Suspected Primary Brain Tumors.
    PLoS One. 2016;11:e0167596.
    PubMed     Abstract available


  406. CHENG Y, Zhao G, Zhang S, Nigim F, et al
    AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
    PLoS One. 2016;11:e0167094.
    PubMed     Abstract available


  407. WESTON C, Klobusicky J, Weston J, Connor J, et al
    Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas.
    PLoS One. 2016;11:e0166593.
    PubMed     Abstract available


  408. CHEN PH, Cheng CH, Shih CM, Ho KH, et al
    The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
    PLoS One. 2016;11:e0167096.
    PubMed     Abstract available


  409. YAMAGUCHI S, Hirata K, Toyonaga T, Kobayashi K, et al
    Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
    PLoS One. 2016;11:e0167917.
    PubMed     Abstract available


  410. ZHANG I, Alizadeh D, Liang J, Zhang L, et al
    Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages.
    PLoS One. 2016;11:e0165118.
    PubMed     Abstract available


  411. GILDER AS, Wang L, Natali L, Karimi-Mostowfi N, et al
    Pertussis Toxin Is a Robust and Selective Inhibitor of High Grade Glioma Cell Migration and Invasion.
    PLoS One. 2016;11:e0168418.
    PubMed     Abstract available


  412. SHIMIZU M, Tanaka M, Atomi Y
    Small Heat Shock Protein alphaB-Crystallin Controls Shape and Adhesion of Glioma and Myoblast Cells in the Absence of Stress.
    PLoS One. 2016;11:e0168136.
    PubMed     Abstract available


  413. KROGH PETERSEN J, Jensen P, Dahl Sorensen M, Winther Kristensen B, et al
    Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
    PLoS One. 2016;11:e0169129.
    PubMed     Abstract available


  414. STEIDL E, Pilatus U, Hattingen E, Steinbach JP, et al
    Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.
    PLoS One. 2016;11:e0168113.
    PubMed     Abstract available


  415. HUHNDORF M, Moussavi A, Kramann N, Will O, et al
    Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma Model.
    PLoS One. 2016;11:e0168174.
    PubMed     Abstract available


  416. LI Y, Hou M, Lu G, Ciccone N, et al
    The Prognosis of Anti-Angiogenesis Treatments Combined with Standard Therapy for Newly Diagnosed Glioblastoma: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0168264.
    PubMed     Abstract available


  417. WEN G, Tang C, Zhong C, Li X, et al
    Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0153397.
    PubMed     Abstract available


  418. LIU S, Wang Y, Fan X, Ma J, et al
    Anatomical Involvement of the Subventricular Zone Predicts Poor Survival Outcome in Low-Grade Astrocytomas.
    PLoS One. 2016;11:e0154539.
    PubMed     Abstract available


  419. SCHOB S, Meyer J, Gawlitza M, Frydrychowicz C, et al
    Diffusion-Weighted MRI Reflects Proliferative Activity in Primary CNS Lymphoma.
    PLoS One. 2016;11:e0161386.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: